Vitamin D Deficiency Activates Gdnf-Ret-pErk1/2 Signal and Induces Kidney Malformations in Mice

Minghui Yu1, Ningli Ye1, Haixin Ju1

  • 1Department of Nephrology, Children's Hospital of Fudan University, Shanghai Kidney Development and Pediatric Kidney Disease Research Center, National Children's Medical Center, Shanghai 201102, China.

Insights

Maternal vitamin D deficiency in mice significantly increases congenital anomalies of the kidney and urinary tract (CAKUT) in offspring. This is linked to altered signaling pathways and epigenetic changes, highlighting vitamin D

Area of Science:

  • Developmental Biology
  • Nephrology
  • Endocrinology

Background:

  • Congenital anomalies of the kidney and urinary tract (CAKUT) are the leading cause of pediatric chronic kidney disease.
  • Maternal hypovitaminosis D is associated with mesoderm-related birth defects, suggesting a link to impaired renal development.

Purpose of the Study:

  • To investigate the causal relationship between maternal vitamin D deficiency (VDD) and the induction of CAKUT in offspring.
  • To explore the underlying molecular mechanisms, including signaling pathways and epigenetic modifications.

Main Methods:

  • Established a maternal VDD mice model using vitamin D-free diets prior to pregnancy.
  • Analyzed CAKUT incidence, ureteric bud development, Gdnf-Ret-p-Erk1/2 signaling, and epigenetic modifications (H3K4me3 CUT&TAG) in offspring.
  • Utilized a p-Erk1/2 antagonist (U0126) for in vivo intervention.

Main Results:

  • Maternal VDD significantly increased CAKUT incidence in neonatal mice (19.4% vs. 2.44%).
  • VDD led to increased Gdnf-Ret-p-Erk1/2 signaling and altered expression of Hnf1β and Robo2 via epigenetic remodeling.
  • Inhibition of p-Erk1/2 signaling partially rescued the CAKUT phenotype.

Conclusions:

  • Maternal vitamin D deficiency is a significant risk factor for inducing CAKUT in offspring.
  • The mechanism involves enhanced Gdnf-Ret-p-Erk1/2 signaling and epigenetic alterations in key developmental genes.
  • Intervention targeting p-Erk1/2 signaling may offer a therapeutic strategy for VDD-induced CAKUT.